Gene Editing Goes to Clincial Trials

by | Apr 30, 2021

Gene Editing Goes to Clincial Trials

by | Apr 30, 2021

pexels edward jenner 4033304

Gene-editing using the groundbreaking CRISPR technology is about to be put to the test in the first-ever clinical trial of the treatment in humans. CRISPR is a protein in bacteria that can be used to manipulate genetic material to, according to Jennifer Doudna, who won last year’s Nobel Prize in Chemistry for the development of CRISPR technology, “alter[] DNA sequences in any cell in a precise fashion, in a programmable fashion.” This remarkable technology has the potential to eliminate all genetic disorders and is already delivering results that scientists say were unimaginable just a few years ago.

As is observed in the Netflix documentary series “Unnatural Selection,” we are now “doing science fiction science,” and have been thrust more quickly than we expected into a new world in which our genetic blueprints can be tweaked and optimized. Many bioethicists see such interventions as a potentially dangerous affront to the natural order, opening a Pandora’s Box of potentially disastrous outcomes we can’t begin to predict.

Yet, it is not at all obvious what the term “natural” means or ought to mean, particularly within the context of a human history defined by technological interventions that necessarily restructure natural reality. We may wonder, for example, whether the domestication of grains was natural, whether the use of vaccines to conquer smallpox and polio was natural, whether turning wolves into dogs tens of thousands of years ago was natural, whether using our knowledge of genetics to safely increase the quality and quantity of our crops was natural, whether the very practice of medicine as we know it today is natural, etc.

Read the rest of this article at The Hill

About David D'Amato

David S. D’Amato is an attorney and adjunct law professor whose writing has appeared at the Institute of Economic Affairs, the Future of Freedom Foundation, the Centre for Policy Studies, the Ludwig von Mises Institute, Liberty Fund’s Online Library of Law and Liberty, the Foundation for Economic Education, and in major newspapers around the world. D’Amato is on the Board of Policy Advisors for the Heartland Institute and he is the Benjamin Tucker Research Fellow at the Molinari Institute’s Center for a Stateless Society. He earned a JD from New England School of Law and an LLM in Global Law and Technology from Suffolk University Law School.

Our Books

latest book lineup.

Related Articles

Related

Last Weekend, Iran Changed Everything

Last Weekend, Iran Changed Everything

On April 13, Iran responded to Israel’s attack on its embassy compound in Damascus that killed seven Iranian officers, including a very senior military official, General Mohammad Reza Zahedi, by launching over 300 drones and missiles at Israel from Iranian soil. U.S....

read more
FISA Exchanges Real Liberty for Phantom Security

FISA Exchanges Real Liberty for Phantom Security

House Speaker Mike Johnson betrayed liberty and the Constitution by making a full-court press to get a “clean” reauthorization of Section 702 of the Foreign Intelligence Surveillance (FISA) Act through the House. Section 702 authorizes warrantless surveillance of...

read more
Embracing Deflation

Embracing Deflation

In recent years, the specter of inflation has loomed large over the global economy, fueled by unprecedented monetary stimulus measures and supply chain disruptions. As prices have surged, concerns about the erosion of purchasing power and the threat of runaway...

read more
One Hundred Years of IRS Political Targeting

One Hundred Years of IRS Political Targeting

One hundred years ago, Senator James Couzens, a Michigan Republican, took to the Senate floor to denounce the Bureau of Internal Revenue for abusing its power and trampling innocent taxpayers. Couzens launched a sweeping Senate investigation of federal tax collectors....

read more